Awarded contractOpenSuppliesPoland

Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62

6 suppliers awarded•15 lots awarded•€1.76M awarded

Buyer: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland

Published Jul 13, 2026Awarded May 31, 2026

Pharmaceutical productsAntineoplastic and immunomodulating agents

Awarded value

€1.76M

Estimated value

€1.76M

Awarded at 100% of estimated value

Award date

May 31, 2026

Winners

Lots awarded

Award values

Notice total

€1.76M

Sum of lot awards

€1.96M

TED notice total and lot-level values do not exactly match.

Winners

Asclepios S.A.

WROCŁAW, POL

2 lots

€563,832 This contract

57 award notices•164 awarded lots•€15.22M total

Roche Polska sp. z o.o.

Warszawa, POL

3 lots

€495,501 This contract

15 award notices•29 awarded lots•€11.86M total

Abbvie sp. z o.o.

WARSZAWA, POL

3 lots

€468,767 This contract

12 award notices•25 awarded lots•€13.13M total

Roche Polska Sp. z o. o.

WARSZAWA, POL

2 lots

€238,846 This contract

20 award notices•36 awarded lots•€56.02M total

Komtur Polska Sp. z o.o.

WARSZAWA, POL

2 lots

€111,917 This contract

20 award notices•25 awarded lots•€8.35M total

Janssen - Cilag Polska Sp. z o.o.

WARSZAWA, POL

2 lots

€49,290 This contract

12 award notices•18 awarded lots•€20.95M total

Lots awarded

Lot	Winner	Award value	Main CPV
LOT-0033	Asclepios S.A.	€335,678	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0039	Asclepios S.A.	€228,154	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0040	Roche Polska sp. z o.o.	€200,447	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0041	Abbvie sp. z o.o.	€200,447	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0038	Abbvie sp. z o.o.	€155,893	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0035	Roche Polska sp. z o.o.	€147,867	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0036	Roche Polska sp. z o.o.	€147,187	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0043	Roche Polska Sp. z o. o.	€143,392	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0037	Abbvie sp. z o.o.	€112,427	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0034	Roche Polska Sp. z o. o.	€95,454	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0044	Komtur Polska Sp. z o.o.	€66,425	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0042	Komtur Polska Sp. z o.o.	€45,492	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0045	Not specified	€32,001	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0031	Janssen - Cilag Polska Sp. z o.o.	€24,797	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0032	Janssen - Cilag Polska Sp. z o.o.	€24,493	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)